Shares in focus: A health check for Glaxo

The pharma giant faces major challenges, so steer clear of the shares, says Phil Oakley.

GlaxoSmithKline (GSK) is one of the most valuable companies on the London stock exchange and it’s not difficult to see why. There are lots of things to like about this pharmaceutical giant. A glance at its accounts shows that GSK is a highly profitable business that generates plenty of spare cash to pay juicy dividends.

But how much should you pay for a business like GSK? Only a few weeks ago, US drug company Pfizer was prepared to spend a lot of money to buy [...]

MoneyWeek magazine

Latest issue:

Magazine cover
A new lease of life?

The drugs transforming old age

The UK's best-selling financial magazine. Take a FREE trial today.
Claim 4 FREE Issues
Shale gas 'fracking' promises to transform Britain's energy market. Find out what it is, what it means, and how to invest.

More from MoneyWeek

What you should really do with your money (2014 Edition)

How to buy and sell penny shares

A beginner's guide to investing in gold

How to invest in British fracking